This review provides a comprehensive overview of the pathogenesis, clinical features, and treatment of enteroviral myocarditis and dilated cardiomyopathy.
Offers clinicians a consolidated reference on enteroviral myocarditis; leaves open gaps for prospective trials on targeted therapies.
This chapter presents epidemiologic data on the incidence of myocarditis and dilated cardiomyopathy (DCM) and their associations with enteroviruses. The pathogenesis of enterovirus-induced heart disease is comprehensively reviewed, with particular attention given to experimental studies elucidating the viral and immunologic mechanisms of the disease process. The chapter gives an overview of pathology, and talks about viral replication in the heart, host defense mechanisms, cell-mediated destruction of myofibers, virus participation in chronic heart disease, autoimmunity, viral infection and cardiac dysfunction, and factors affecting disease severity. Next, it reviews the detection of enteroviral infection in patients with myocarditis and DCM. It also describes the clinical features of myocarditis and DCM, and discusses evidence that these diseases are two ends of the same disease spectrum. Finally, the chapter reviews conventional treatments for patients with myocarditis and DCM. In addition, the role of immunosuppression and future avenues of therapy are also examined.
No takes yet. Share an insight, caveat, or question.
Martino et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: